Unorthodox Ventures
Venture capitalAustin · Pre-Seed–Growth · 15 people tracked
Find your way into Unorthodox Ventures
861 people in our graph share verified history with the Unorthodox Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Unorthodox Ventures positions itself as a contrarian VC backed by a single limited partner, enabling fast decisions and a focus on long-term success rather than short-term returns. It invests at seed and Series A, with later-stage follow-ons possible, writing checks of $1M-$5M. Rather than coming from a banking background, its team draws on engineering and marketing expertise to help portfolio companies with PR, manufacturing, and go-to-market strategy for pre-revenue startups. The firm invests globally and frequently helps overseas companies establish their first U.S. offices, offering free space at its 30,000-square-foot Austin warehouse for storage, products, and initial staff.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from the firm's website & public directoriesWhat they invest in
from 8 of 9 portfolio companiesHealthtech ×6Medical Devices ×5Biotech ×2Digital Health ×2Hardware ×2Robotics ×2AI & Machine Learning ×1Construction Tech ×1
HQs:United States×8
Investments · 9 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 42021 · 17 dated
KewaZo builds construction automation technology, including robotic systems for material transport at industrial and construction sites, aimed at reducing crane time and improving safety.
Construction TechHardwareRobotics
Ekaterina Grib(Founder)inArtem Kuchukov(Founder)inLeonidas Pozikidis(Founder)in
Co-investorsSchooner CapitalBenson CapitalChevron Technology VenturesCybernetix VenturesFifth WallGaingels+1 more
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation.
HealthtechMedical DevicesPlymouth, US
Ramji Iyer(Executive Officer, Director)in
BoardJenny H. Barba(Director)Todd Mortier(Director)Colin Morrison(Director)
Co-investorsAphelion Capitalgener8torShangBay Capital LLCAphelion CardeationEngage Venture Partners
Laza Medical develops an AI- and robotics-powered ultrasound imaging system for structural heart, electrophysiology, and diagnostic cardiac procedures, combining real-time 3D heart modeling, procedural guidance, and robotic probe control.
AI & Machine LearningBiotechMedical DevicesRoboticsCampbell, US
Amr Salahieh(Executive Officer, Director, Promoter)Pablo Garcia Kilroy(General Manager)inCasey Gordon(Director)Mariam Maghribi(Executive Officer)David Voris(Executive Officer)
Co-investors415 CapitalPage One VenturesThe Capital Partnership
Sonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products.
BiotechDigital HealthHealthtechMedical DevicesBaltimore, US
David Narrow(Executive Officer, Director)inDevin O'Brien-Coon(Co-Founder & Chairman)inJerry L. Prince(Co-Founder)inJohn Rappe(Executive Officer)inAlex Yevzlin(Executive Officer)
BoardRobert Hallenbeck(Director)
Co-investorsFusionJStar Capital InvestmentsKeiretsu ForumMaryland TEDCORembrandt Venture PartnersRiptide Ventures+2 more
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.
HardwareHealthtechMedical DevicesCampbell, US
Nitin Salunke(President & CEO)inJean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)
BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)
Co-investors415 CapitalAmed VenturesThe Capital PartnershipNovo Holdings
Vibrant Gastro develops a drug-free medical device using micro-vibrations to treat chronic idiopathic constipation in adults.
ConsumerDigital HealthHealthtechMedical DevicesItasca, US
Lior Ben Tsur(CEO & Co-Founder)in
PartnerCarey Smith· solo GP
Co-investorsGefen CapitalSequoia Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Portfolio news
latest coverage across their companiesSonavex · intelligence360.news · Aug 10, 2026
Laplace Interventional · tipranks.com · May 9, 2026
Kewazo · theaiinsider.tech · Mar 20, 2026
Akura Medical · medtechdive.com · Dec 3, 2025
Frequently asked questions
- How many investments has Unorthodox Ventures made?
- Unorthodox Ventures has 9 tracked investments, including 2 dated in the last 24 months.
- What stage does Unorthodox Ventures invest at?
- Unorthodox Ventures invests at the Pre-Seed, Seed, Series A, Series B, Growth stages.
- What is Unorthodox Ventures's typical check size?
- Unorthodox Ventures typically writes checks of $1M – $5M.
- What sectors does Unorthodox Ventures focus on?
- Unorthodox Ventures focuses on Construction Tech, Medical Devices, Sector Agnostic.
- Where is Unorthodox Ventures located?
- Unorthodox Ventures is headquartered in Austin, US.
Media · Podcasts & interviews
featuring the teamFireside chat with Carey Smith, Unorthodox Ventures hosted by Jan Ameri, ArcticStartup
ArcticStartup · Carey Smith
Carey Smith, Founder Unorthodox Ventures, Chief Big Ass Fans, sold for $500Million
Eliances.com · Carey Smith
Similar investors
Almi Invest is a Swedish state-owned venture capital company that invests in early-stage startups and growth companies with scalable business models, operating through regional funds and a national GreenTech Fund.
Angel Bridge is a Japanese venture capital firm that emphasizes hands-on support as a 'supporter of entrepreneurs,' aiming to help create world-class mega ventures.
MaRS is a Toronto-based innovation hub and accelerator that supports Canadian startups from pre-seed funding through international expansion, offering workspace, mentorship, investor and customer connections, and sector-focused programming.
Skolkovo Foundation is a Russian innovation ecosystem supporting startups from idea to successful business through grants, investment reimbursement, and infrastructure.
Asahi Kasei Corporate Venture Capital, established in 2008, invests in innovative global companies across materials, homes, and healthcare sectors. The firm identifies strategic opportunities aligned with Asahi Kasei's core business, with offices in Menlo Park, Boston, Düsseldorf, and Shanghai.

















__Twitter.png)
























